Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Galer

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Epilepsy & Behavior : E&B|December 4, 2022
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopmentKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.
JAMA Neurology|December 3, 2019
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical TrialRima Nabbout, Arun Mistry, Sameer Zuberi, et al.
Epilepsy & Behavior : E&B|August 5, 2021
Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growthAntonio Gil-Nagel, Joseph Sullivan, Berten Ceulemans, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
The British Journal of Radiology|September 27, 2014
Future development of biologically relevant dosimetryH Palmans, H Rabus, A L Belchior, et al.
Epilepsia|August 6, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trialJoseph Sullivan, Lieven Lagae, J Helen Cross, et al.
JAMA Neurology|May 2, 2022
Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical TrialKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Epilepsia|October 5, 2022
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension studyKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Archives of Neurology|November 19, 2003
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendationsRobert H Dworkin, Miroslav Backonja, Michael C Rowbotham, et al.
Pain|December 9, 2003
Core outcome domains for chronic pain clinical trials: IMMPACT recommendationsDennis C Turk, Robert H Dworkin, Robert R Allen, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Epilepsy & Behavior : E&B|December 4, 2022
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopmentKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.
JAMA Neurology|December 3, 2019
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical TrialRima Nabbout, Arun Mistry, Sameer Zuberi, et al.
Epilepsy & Behavior : E&B|August 5, 2021
Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growthAntonio Gil-Nagel, Joseph Sullivan, Berten Ceulemans, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
The British Journal of Radiology|September 27, 2014
Future development of biologically relevant dosimetryH Palmans, H Rabus, A L Belchior, et al.
Epilepsia|August 6, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trialJoseph Sullivan, Lieven Lagae, J Helen Cross, et al.
JAMA Neurology|May 2, 2022
Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical TrialKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Epilepsia|October 5, 2022
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension studyKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Archives of Neurology|November 19, 2003
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendationsRobert H Dworkin, Miroslav Backonja, Michael C Rowbotham, et al.
Pain|December 9, 2003
Core outcome domains for chronic pain clinical trials: IMMPACT recommendationsDennis C Turk, Robert H Dworkin, Robert R Allen, et al.
Pageof 13